残余胆固醇对急性冠脉综合征患者冠状动脉内薄纤维帽粥样硬化斑块的预测价值及其与斑块易损特征的相关性
收稿日期: 2026-04-18
网络出版日期: 2026-08-05
基金资助
山东省医药卫生科技项目(202503010899)
Predictive value of remnant cholesterol for intracoronary thin-cap fibroatheroma and its correlation with plaque vulnerability features in patients with acute coronary syndrome
Received date: 2026-04-18
Online published: 2026-08-05
目的 探讨残余胆固醇(RC)对急性冠脉综合征(ACS)患者冠状动脉内薄纤维帽粥样硬化斑块(TCFA)的预测价值,并分析其与斑块易损特征的关系。 方法 回顾性纳入2024年1月至2025年12月在山东第一医科大学附属菏泽医院因胸痛或疑似心肌缺血住院并行冠状动脉造影的患者186例,依据临床诊断与造影结果分为ACS组(n = 117)和非ACS组(n = 69)。ACS组均完成光学相干断层成像(OCT),根据OCT结果分为TCFA组(n = 49)与非TCFA组(n = 68)。比较各组临床与血脂资料,以多因素logistic回归筛选ACS患者冠状动脉内TCFA的独立相关因素,以受试者工作特征(ROC)曲线评价RC对TCFA的预测价值,并用Spearman秩相关分析RC与OCT斑块特征的关联。 结果 ACS组和非ACS组患者总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、RC及高密度脂蛋白胆固醇(HDL-C)水平差异有统计学意义(P < 0.05)。ACS患者中TCFA组吸烟史、糖尿病史比例及TC、LDL-C、RC水平与非TCFA组比较,差异有统计学意义(P < 0.05)。多因素logistic回归分析显示,糖尿病史、吸烟史、LDL-C升高及RC升高(OR = 2.917,95%CI:1.407 ~ 6.048)是ACS患者冠状动脉内TCFA的独立相关因素(P < 0.05)。ROC分析显示,RC预测ACS患者冠状动脉内TCFA的曲线下面积(AUC)为0.702(95%CI:0.600 ~ 0.803),最佳截断值为0.975 mmol/L,敏感度和特异度分别为0.653和0.794。Spearman秩相关分析显示,RC与最大脂质弧度、巨噬细胞浸润呈正相关(rs = 0.438、0.248,P < 0.05),与最薄纤维帽厚度、最小管腔面积(MLA)呈负相关(rs = -0.369、-0.342,P < 0.05)。 结论 RC升高是ACS患者冠状动脉内TCFA的独立相关因素,对TCFA具有一定预测价值,并与纤维帽变薄、脂质弧度增大、MLA减小及巨噬细胞浸润增加等斑块易损特征相关。RC可为ACS患者冠状动脉内高危斑块的风险分层提供参考。
关键词: 急性冠脉综合征; 残余胆固醇; 薄纤维帽粥样硬化斑块; 光学相干断层成像; 斑块易损特征
董文倩 , 陈贝健 , 李国庆 , 张怀鹏 , 贾玉卿 , 高桂丽 , 杨红 , 刘静 , 王华 , 王向兵 , 于祥浩 , 侯秋宇 , 许晓宇 . 残余胆固醇对急性冠脉综合征患者冠状动脉内薄纤维帽粥样硬化斑块的预测价值及其与斑块易损特征的相关性[J]. 实用医学杂志, 2026 , 42(14) : 2505 -2512 . DOI: 10.3969/j.issn.1006-5725.2026.14.003
Objective To investigate the predictive value of remnant cholesterol (RC) for intracoronary thin-cap fibroatheroma (TCFA) in patients with acute coronary syndrome (ACS) and analyze its relationship with plaque vulnerability features. Methods A total of 186 patients who were hospitalized for chest pain or suspected myocardial ischemia and underwent coronary angiography at Heze Hospital Affiliated to Shandong First Medical University from January 2024 to December 2025 were retrospectively enrolled. These patients were divided into an ACS group (n = 117) and a non-ACS group (n = 69) based on clinical and angiographic findings. All ACS patients underwent optical coherence tomography (OCT) and were further classified into a TCFA group (n = 49) and a non-TCFA group (n = 68). Clinical data and lipid profiles were compared among the groups. Multivariable logistic regression was employed to identify independent factors for intracoronary TCFA, ROC curve analysis was used to evaluate the predictive value of RC, and Spearman rank correlation was utilized to assess the associations between RC and OCT-derived plaque features. Results Total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), remnant cholesterol (RC), and high-density lipoprotein cholesterol (HDL-C) exhibited significant differences between the ACS and non-ACS groups (P < 0.05). Among ACS patients, the TCFA group significantly differed from the non-TCFA group in terms of the proportions of patients with a history of smoking and diabetes mellitus, as well as the levels of TC, LDL-C, and RC (P < 0.05). Multivariable analysis revealed that diabetes, smoking, elevated LDL-C, and elevated RC (odds ratio [OR] = 2.917, 95% confidence interval [CI]: 1.407 - 6.048) were independent risk factors for intracoronary TCFA (P < 0.05). Receiver operating characteristic (ROC) curve analysis demonstrated that the area under the curve (AUC) of RC for predicting intracoronary TCFA was 0.702 (95%CI: 0.600 ? 0.803), with an optimal cutoff value of 0.975 mmol/L, a sensitivity of 0.653, and a specificity of 0.794. Spearman rank correlation analysis indicated that RC was positively correlated with the maximum lipid arc and macrophage infiltration (rs = 0.438 and 0.248, respectively; P < 0.05), and negatively correlated with the thinnest fibrous cap thickness and minimum lumen area (MLA) (rs = -0.369 and -0.342, respectively; P < 0.05). Conclusions Elevated RC is an independent factor associated with intracoronary TCFA in patients with ACS and possesses a certain predictive value for TCFA. It is also correlated with features of plaque vulnerability, such as a thinner fibrous cap, a larger lipid arc, a smaller MLA, and increased macrophage infiltration. RC can serve as a reference for the risk stratification of high-risk coronary plaques in patients with ACS.
| [1] | BHATT D L, LOPES R D, HARRINGTON R A. Diagnosis and treatment of acute coronary syndromes: A review[J]. JAMA, 2022, 327(7): 662. doi:10.1001/jama.2022.0358 . |
| [2] | CREA F, LIBBY P. Acute coronary syndromes: The way forward from mechanisms to precision treatment[J]. Circulation, 2017, 136(12): 1155-1166. doi:10.1161/circulationaha.117.029870 . |
| [3] | BYRNE R A, ROSSELLO X, COUGHLAN J J, et al. 2023 ESC Guidelines for the management of acute coronary syndromes[J]. Eur Heart J, 2023, 44(38): 3720-3826. doi:10.1093/eurheartj/ehad191 . |
| [4] | STONE G W, MAEHARA A, LANSKY A J, et al. A prospective natural-history study of coronary atherosclerosis[J]. N Engl J Med, 2011, 364(3): 226-235. doi:10.1056/nejmoa1002358 . |
| [5] | LIBBY P. Mechanisms of acute coronary syndromes and their implications for therapy[J]. N Engl J Med, 2013, 368(21): 2004-2013. doi:10.1056/NEJMra1216063 . |
| [6] | BENTZON J F, OTSUKA F, VIRMANI R, et al. Mechanisms of plaque formation and rupture[J]. Circ Res, 2014, 114(12): 1852-1866. doi:10.1161/circresaha.114.302721 . |
| [7] | NORDESTGAARD B G, VARBO A. Triglycerides and cardiovascular disease[J]. Lancet, 2014, 384(9943): 626-635. doi:10.1016/S0140-6736(14)61177-6 . |
| [8] | ROSENSON R S, DAVIDSON M H, HIRSH B J, et al. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease[J]. J Am Coll Cardiol, 2014, 64(23): 2525-2540. doi:10.1016/j.jacc.2014.09.042 . |
| [9] | SANDESARA P B, VIRANI S S, FAZIO S, et al. The forgotten lipids: Triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk[J]. Endocr Rev, 2019, 40(2): 537-557. doi:10.1210/er.2018-00184 . |
| [10] | WANG K, WANG R, YANG J, et al. Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment[J]. Front Cardiovasc Med, 2022, 9: 913869. doi:10.3389/fcvm.2022.913869 . |
| [11] | HONG H, JIA H, ZENG M, et al. Risk stratification in acute coronary syndrome by comprehensive morphofunctional assessment with optical coherence tomography[J]. JACC Asia, 2022, 2(4): 460-472. doi:10.1016/j.jacasi.2022.03.004 . |
| [12] | XING L, HIGUMA T, WANG Z, et al. Clinical significance of lipid-rich plaque detected by optical coherence tomography[J]. J Am Coll Cardiol, 2017, 69(20): 2502-2513. doi:10.1016/j.jacc.2017.03.556 . |
| [13] | FALK E, NAKANO M, BENTZON J F, et al. Update on acute coronary syndromes: The pathologists' view[J]. Eur Heart J, 2013, 34(10): 719-728. doi:10.1093/eurheartj/ehs411 . |
| [14] | AGUIRRE A D, ARBAB-ZADEH A, SOEDA T, et al. Optical coherence tomography of plaque vulnerability and rupture JACC focus seminar part 1/3[J]. J Am Coll Cardiol, 2021, 78(12): 1257-1265. doi:10.1016/j.jacc.2021.06.050 . |
| [15] | 中国医师协会急诊医师分会, 国家卫健委能力建设与继续教育中心急诊学专家委员会, 中国医疗保健国际交流促进会急诊急救分会. 急性冠脉综合征急诊快速诊治指南(2019)[J]. 中华急诊医学杂志, 2019, 28(4): 421-428. doi:10.3760/cma.j.issn.1671-0282.2019.04.003 . |
| [16] | TEARNEY G J, REGAR E, AKASAKA T, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies[J]. J Am Coll Cardiol, 2012, 59(12): 1058-1072. doi:10.1016/j.jacc.2011. 09.079 . |
| [17] | JOHNSON T W, R?BER L, DI MARIO C, et al. Clinical use of intracoronary imaging. Part 2: Acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions[J]. Eur Heart J, 2019, 40(31): 2566-2584. doi:10.1093/eurheartj/ehz332 . |
| [18] | 闫海浩, 张飞飞, 党懿. 残余胆固醇与急性冠脉综合征患者易损斑块特征的相关性研究[J]. 中国全科医学, 2023, 26(26): 3303-3307, 3313. doi:10.12114/j.issn.1007-9572.2023.0093 . |
| [19] | DURAN E K, PRADHAN A D. Triglyceride-rich lipoprotein remnants and cardiovascular disease[J]. Clin Chem, 2021, 67(1): 183-196. doi:10.1093/clinchem/hvaa296 . |
| [20] | 钱程昱, 王琳升, 熊兴江, 等. 血清低密度脂蛋白胆固醇、超敏C反应蛋白联合颈动脉超声参数诊断疑似冠心病患者的价值[J]. 实用医学杂志, 2025, 41(9): 1401-1406. doi:10.3969/j.issn.1006-5725.2025.09.019 . |
| [21] | LIAO J, QIU M, SU X, et al. The residual risk of inflammation and remnant cholesterol in acute coronary syndrome patients on statin treatment undergoing percutaneous coronary intervention[J]. Lipds Health Dis, 2024, 23(1): 172. doi:10.1186/s12944-024-02156-3 . |
| [22] | HASHIMOTO T, MINAMI Y, ASAKURA K, et al. Lower levels of low-density lipoprotein cholesterol are associated with a lower prevalence of thin-cap fibroatheroma in statin-treated patients with coronary artery disease[J]. J Clin Lipidol, 2022, 16(1): 104-111. doi:10.1016/j.jacl.2021.11.012 . |
| [23] | NICHOLLS S J, KATAOKA Y, NISSEN S E, et al. Effect of evolocumab on coronary plaque phenotype and burden in statin-treated patients following myocardial infarction[J]. JACC Cardiovasc Imag, 2022, 15(7): 1308-1321. doi:10.1016/j.jcmg.2022. 03.002 . |
| [24] | ABTAHIAN F, YONETSU T, KATO K, et al. Comparison by optical coherence tomography of the frequency of lipid coronary plaques in current smokers, former smokers, and nonsmokers[J]. Am J Cardiol, 2014, 114(5): 674-680. doi:10.1016/j.amjcard.2014.05.056 . |
| [25] | KEDHI E, BERTA B, ROLEDER T, et al. Thin-cap fibroatheroma predicts clinical events in diabetic?patients with normal fractional flow reserve: The COMBINE OCT-FFR trial[J]. Eur Heart J, 2021, 42(45): 4671-4679. doi:10.1093/eurheartj/ehab433 . |
| [26] | SOROKIN A V, PATEL N, LI H, et al. Estimated sdLDL-C for predicting high-risk coronary plaque features in psoriasis: A prospective observational study[J]. Lipds Health Dis, 2023, 22(1): 55. doi:10.1186/s12944-023-01819-x . |
| [27] | QUISPE R, MARTIN S S, MICHOS E D, et al. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: A primary prevention study[J]. Eur Heart J, 2021, 42(42): 4324-4332. doi:10.1093/eurheartj/ehab432 . |
| [28] | SHAO Q Y, YANG Z Q, WANG Y F, et al. Elevated remnant cholesterol is associated with adverse cardiovascular outcomes in patients with acute coronary syndrome[J]. J Atheroscler Thromb, 2022, 29(12): 1808-1822. doi: 10.5551/jat.63397 . |
| [29] | 巨名飞, 刘超, 马志刚, 等. 残余胆固醇水平对急性冠脉综合征患者发病的预测价值[J]. 吉林大学学报(医学版), 2023, 49(3): 765-769. doi:10.13481/j.1671-587X.20230327 . |
| [30] | VARBO A, NORDESTGAARD B G. Remnant cholesterol and risk of ischemic stroke in 112, 512 individuals from the general population[J]. Ann Neurol, 2019, 85(4): 550-559. doi:10. 1002/ana.25432 . |
| [31] | ALLOZA I, SALEGI A, MENA J, et al. BIRC6 is associated with vulnerability of carotid atherosclerotic plaque[J]. Int J Mol Sci, 2020, 21(24): 9387. doi:10.3390/ijms21249387 . |
| [32] | TADA H, NOHARA A, INAZU A, et al. Remnant lipoproteins and atherosclerotic cardiovascular disease[J]. Clin Chim Acta, 2019, 490: 1-5. doi:10.1016/j.cca.2018.12.014 . |
| [33] | HANSSON G K, LIBBY P, TABAS I. Inflammation and plaque vulnerability[J]. J Intern Med, 2015, 278(5): 483-493. doi:10.1111/joim.12406 . |
| [34] | NEWBY A C. Metalloproteinase production from macrophages?a perfect storm leading to atherosclerotic plaque rupture and myocardial infarction[J]. Exp Physiol, 2016, 101(11): 1327-1337. doi:10.1113/EP085567 . |
| [35] | MATTHEWS C, GORENNE I, SCOTT S, et al. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: Effects of telomerase and oxidative stress[J]. Circ Res, 2006, 99(2): 156-164. doi:10.1161/01.res.0000233315. 38086.bc . |
| [36] | CHILDS B G, BAKER D J, WIJSHAKE T, et al. Senescent intimal foam cells are deleterious at all stages of atherosclerosis[J]. Science, 2016, 354(6311): 472-477. doi:10.1126/science.aaf6659 . |
| [37] | 巨名飞, 刘超, 刘佳梅, 等. 急性冠状动脉综合征患者残余胆固醇水平与冠状动脉狭窄严重程度的相关性[J]. 实用医学杂志, 2023, 39(1): 71-75. doi:10.3969/j.issn.1006-5725.2023. 01.012 . |
| [38] | UEMURA S, ISHIGAMI K I, SOEDA T, et al. Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques[J]. Eur Heart J, 2012, 33(1): 78-85. doi:10.1093/eurheartj/ehr284 . |
| [39] | DAI J, TIAN J, HOU J, et al. Association between cholesterol crystals and culprit lesion vulnerability in patients with acute coronary syndrome: An optical coherence tomography study[J]. Atherosclerosis, 2016, 247: 111-117. doi:10.1016/j.atherosclerosis.2016.02.010 . |
/
| 〈 |
|
〉 |